baber/WOPTO huggingface dataset:
Patent EP-0726903-B1 (EP)
Inventor: CASTELHANO ARLINDO L
IPC: C07D295/13
Filed: 1994-11-03
Granted: 1997-07-16
Abstract: This invention is directed to compounds of formula (I): wherein R<1> is mercapto, acetylthio, carboxy, hydroxycarbamoyl, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, benzyloxycarbamoyl or (i) (where R<6> is optionally substituted aryl, wherein the aryl group is quinol-2-yl, naphth-1-yl, naphth-2-yl, pyridyl or phenyl); R<2> is alkyl, aralkyl or cycloalkylalkyl; R<3> is cycloalkyl, alkyl (optionally substituted by cycloalkyl, hydroxy, mercapto, alkylthio, aralkoxy, carboxy, amino, alkylamino, guanidino, carbamoyl, pyridyl or indolyl), or aralkyl (optionally substituted by hydroxy, carboxy, alkyl or alkoxy); R<4> is nitro, amino, cyano, hydroxy, alkoxy, carboxy, alkoxycarbonyl, alkylsulfonyl, haloalkyl, alkoxycarbonylalkyl, tetrazolyl, carbamoyl (optionally substituted by alkyl or dialkylaminoalkyl), or aminosulfonyl (optionally substituted by alkyl); and R<5> is hydrogen, halo or hydroxy; as single stereoisomers or as mixtures thereof; or the pharmaceutically acceptable salts thereof. These compounds are useful in inhibiting matrix metalloprotease activity in mammals.
Patent EP-0677308-B1 (EP)
Inventor: SCHARY PHILIPPE
IPC: A63C9/08
Filed: 1995-02-22
Granted: 1997-08-27
Abstract: The binding has a body with a base (21) made in plastics material. This is reinforced by two side plates (23,24) joined by an upper plate (29) which are made in metal. These fit over the body and extend between the axis of articulation of the binding and the runners (36). The lower part of the reinforcing has horizontal edges (31,32) which are engaged along the lateral edges of the runner. The horizontal edges of the side plates (33,34) are covered with anti-friction material and extends continuously from the runners. <IMAGE>
Patent EP-0712619-B1 (EP)
Inventor: KITABJIAN MARY S
IPC: A61F13/15
Filed: 1995-09-28
Granted: 2002-08-28
Abstract: An absorbent product useful for wearing in the crotch portion of an undergarment is disclosed. The absorbent product has an absorbent structure disposed between a body-facing surface (12) and a garment-facing surface (14), a positioning element (22) operatively connected to the garment-facing surface (14), and conforming means (18). The conforming means (18) include an association of conformable segments (20) which are movable with respect to one another. The absorbent product is capable of acquiring and maintaining a form which conforms to a user's body surface contours. <IMAGE>
Patent EP-0706863-B1 (EP)
Inventor: ACHILLES GERHARD
IPC: B32B37/22
Filed: 1993-03-23
Granted: 2000-11-29
Abstract: The laminate mfg. process uses a pair of controlled laminating rollers for combining a thin adhesive-coated foil with individual or endless sheets (2) using a floating application pressure of between 10 and 50 N/cm. Pref. the foil is coated with UV hardened adhesive via a coating roller with a rotation rate which is matched to the lamination rate via a computer, supplied with the processing rate and the sheet length etc.
Patent EP-0748464-B1 (EP)
Title: Sensitizers for photothermographic elements
Inventor: MILLER JAMES R
IPC: G03C1/12
Filed: 1995-01-06
Granted: 1998-06-24
Abstract: Photothermographic elements of the photothermographic type may be sensitized to the infrared with sensitizing dyes of the formula:    <IMAGE>   wherein: R1 represents a (CH2)n-COO- group of from 1-20 carbon atoms, or an alkyl group of from 1 to 20 carbon atoms; and n is an integer from 1 to 20.
Patent EP-0756809-B1 (EP)
Inventor: SPARER RONALD M
IPC: F28F21/08
Filed: 1995-01-31
Granted: 1998-07-01
Abstract: Système de refroidissement (10) qui fait circuler un liquide de refroidissement dans les carters (38) de moteur et les surfaces (22) de montage de composants électriques et électroniques. Ce système est particulièrement économique dans des installations dotées de moteurs électriques multiples (103, 124, 148, 156) et d'entraînement électroniques associés (44, 46, 48, 50), telles que des machines électriques de transformation de plastiques. Spécifiquement, les moteurs (103, 124, 148, 156) sont pourvus d'un carter (38) et d'un échangeur de chaleur construits d'un seul tenant, tel que des tuyaux en acier inoxydable (40) coulés dans un carter de stator cylindrique en aluminium. Les différents composants électriques et électroniques de la machine sont montés sur la surface d'un échangeur de chaleur en forme de plaque ou plaque réfrigérante (22) qui se trouve dans le logement (56) destiné au circuit électrique primaire. De plus, l'air se trouvant dans l'enceinte électrique (56) est amené à circuler en permanence sur la plaque réfrigérante (22) pour fournir une répartition plus uniforme de la température dans l'enceinte (56) et réduire au minimum la condensation sur la surface de la plaque (22). La chaleur générée par les moteurs (103, 124, 148, 156) et le système électronique est absorbée à partir des carters (38) de moteur et de la plaque réfrigérante (22) par le liquide en circulation, et libérée à travers un échangeur de chaleur (16). Des résistances électriques (34, 36) sont moulées dans la plaque réfrigérante si bien que le transfert de chaleur à partir de ces éléments est optimisé et que l'on gagne de l'espace en construisant ce dispositif d'un seul tenant.
Patent EP-0777451-B1 (EP)
Inventor: COHEN SMADAR
IPC: A61K47/36
Filed: 1995-06-19
Granted: 2001-12-19
Abstract: The present invention relates to formulations particularly well suited for use as delivery systems in the delivery of an active agent to the eye. The formulations comprise an alginate having a particular proportion of guluronic acid.
Patent EP-0770280-B1 (EP)
Inventor: WINFIELD PHILLIP ROLAND
IPC: H02G15/184
Filed: 1995-07-10
Granted: 1999-03-03
Abstract: A 15kv cable joint is enclosed within two half shells filled with sealant material (46). A Faraday Cage (28C) is disposed within the sealant material (46) around the jointed conductors. In order to maintain the Faraday Cage (28C) in position, an insulating support (150) is located in the sealant material (46) and fixed to the half shells.
Patent EP-0769949-B1 (EP)
Inventor: MERRIL SONYA
IPC: A61K9/00
Filed: 1995-06-23
Granted: 2003-01-15
Abstract: An oral hydromorphone composition for the management of pain comprising dosage form providing analgesia via the oral route over an extended period of time, comprising a therapeutic composition comprising 1 to 1000mg of hydromorphone; 25 to 500mg of carboxymethylcellulose of 10,000 to 300,000 mw as a polymeric carrier; a binder agent selected from at least one of the 1 to 50mg of poly (vinyl) pyrrolidone of 10,000 to 300,000 mw or 1 to 50mg of hydroxypropylcellulose or hydroxypropylalkylcellulose of 7,500 to 75,000 mw; and 0 to 10 mg of a lubricant.
Patent EP-0773783-B1 (EP)
Inventor: RASMUSSEN ERIK PREBEN
IPC: A61K31/56
Filed: 1995-07-21
Granted: 2001-11-28
Abstract: The preparation of fusidic acid sodium salt tablets without an enteric coating in which the active ingredient in dry powdered form is compressed in a roller compactor, followed by size reduction to form a granulate for tabletting.
Patent EP-0777845-B1 (EP)
Inventor: KINNERSLY RICHARD FURNEAUX
IPC: F28F1/20
Filed: 1995-09-04
Granted: 1999-12-08
Abstract: PCT No. PCT/GB95/02086 Sec. 371 Date Feb. 27, 1997 Sec. 102(e) Date Feb. 27, 1997 PCT Filed Sep. 4, 1995 PCT Pub. No. WO96/07864 PCT Pub. Date Mar. 14, 1996A heat exchanger element comprises an outer tube (11), an inner tube (12) within the outer tube and a first fluid flow path for a first heat exchange fluid formed between the inner and outer tubes. A second heat exchange fluid is in heat transfer relation to the outer surface of the outer tube and/or the inner surface of the inner tube. A sleeve (13) is provided within the first fluid flow path between the inner and outer tubes. The sleeve defines an outer interface (16) with the inner surface of the outer tube and an inner interface (14) with the outer surface of the inner tube. Generally longitudinal grooves (16,17) are provided at each interface to provide together the first fluid flow path.
Patent EP-0778770-B1 (EP)
Inventor: MAYER DAVID J
IPC: A61K31/415
Filed: 1995-08-29
Granted: 2003-12-10
Abstract: The analgesic effectiveness of a non-narcotic analgesic such as an NSAID or acetaminophen is significantly enhanced by administering the NSAID or acetaminophen prior to, with or following the administration of an analgesia enhancer which is a nontoxic NMDA receptor blocker and/or a nontoxic substance that blocks at least one major intracellular consequence of NMDA recpetor activation.
Patent EP-0737331-B1 (EP)
Title: Systeme de commande et moyen de commande pour regler une quantite de ce systeme de commande
Inventor: SCHOOTSTRA GERRIT
IPC: G05B21/02
Filed: 1995-09-29
Granted: 2001-12-19
Abstract: Dans un système de commande, une quantité caractéristique d'un processus (1) présente une perturbation périodique. Un système de mesure (2) génère un signal de mesure (Vm) représentant la quantité caractéristique. Un dispositif commande le processus en réaction au signal de mesure (Vm). Afin de diminuer la perturbation périodique, le dispositif de commande (3) comprend un circuit de retard (4) qui retarde un signal d'entrée (Vin) relatif au signal de mesure (Vm), d'un intervalle temporel (T) possédant la longueur d'une période (Tp) de la perturbation périodique. Le dispositif de commande (3) comprend un circuit d'analyse (6) servant à calculer un signal d'analyse (Va) indiquant une déviation entre la période de la perturbation périodique et le temps de retard. Un circuit de commande (13) et un circuit d'adaptation (7) permettent de régler le temps de retard (T) en fonction du signal d'analyse (Va) à une valeur pour laquelle le signal d'analyse (Va) indique que le temps de retard (T) est égal à la période (Tp). Un système de corrélation peut s'utiliser pour calculer le signal d'analyse (Va).
Patent EP-0782588-B1 (EP)
Inventor: ZINGDE GURUDAS
IPC: C08L67/02
Filed: 1995-08-24
Granted: 2002-03-13
Abstract: Additifs retardateurs de flammes pour matières plastiques, composition renfermant de tels additifs et méthodes d'élaboration de ces additifs et de ces compositions. Ces additifs renferment un copolymère halostyrène et glycidyl (méth)acrylate. Ces compositions renferment un substrat thermoplastique nécessitant une ignifugation et des copolymères halostyrène et glycidyl (méth)acrylate.
Patent EP-0781380-B1 (EP)
Inventor: BUTTERFIELD ROBERT D
IPC: F04B43/08
Filed: 1995-09-08
Granted: 2002-04-24
Abstract: A pumping mechanism moving in movement increments is controlled to space those movement increments in direct proportion to the volume resulting from each movement increment. In a further aspect, movement increments are grouped to result in approximately equal volumes per group. The mechanism moves continuously through the movement increments in each group. Groups are spaced to result in approximately equal flow volumes per group. The number of groups decreases as the flow rate increases. The number of movement increments in each group and the volume of each group increase as the flow rate increases.
Patent EP-0789708-B1 (EP)
Inventor: BOUTIN RAYMOND H
IPC: C12N15/87
Filed: 1995-09-28
Granted: 2004-11-03
Abstract: A multifunctional molecular complex for the transfer of a nucleic acid composition to a target cell is provided The complex is comprised of A) said nucleic acid composition and B) a transfer moiety comprising 1) one or more cationic polyamines bound to said nucleic acid composition, 2) one or more endosome membrane disrupting components attached to at least one nitrogen of the polyamine and 3) one or more receptor specific binding components.
Patent EP-0795015-B1 (EP)
Inventor: HOBART PETER M
IPC: A61K47/44
Filed: 1995-11-28
Granted: 2004-03-24
Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods. The plasmid consists essentially of an expression facilitating sequence derived from the immediate-early promoter region of CMV, an expression facilitating sequence derived from the transcriptional termination/polyadenylation signal sequence of the BGH gene, a sequence coding for the eukaryotic expression of an IL-2, possessing a bioactivity of the complete IL-2, operably linked to both of said expression facilitating augments eukaryotic expression compared to a wild-type IL-2 leader peptide. Optionally, the plasmid also includes a non-mammalian origin of replication and a sequence operably encoding a selectable marker.
Patent EP-0796143-B1 (EP)
Inventor: SENTAGNES DOMINIQUE
IPC: A62D101/20
Filed: 1995-12-05
Granted: 1998-10-07
Abstract: PCT No. PCT/FR95/01600 Sec. 371 Date Jul. 24, 1997 Sec. 102(e) Date Jul. 24, 1997 PCT Filed Dec. 5, 1995 PCT Pub. No. WO96/17680 PCT Pub. Date Jun. 13, 1996Chemical transformation of complex chemical structures in a supercritical medium. The transformation of one or more chemical structures (20) involves at least one reduction reaction in a solvent (22) in the supercritical state. Application to the destruction of dangerous products, the treatment of industrial effluents and natural products and the modification of molecular structures.
Patent EP-0736523-B1 (EP)
Inventor: SANDLER STANLEY R
IPC: C07B61/00
Filed: 1996-03-01
Granted: 2000-05-17
Abstract: Novel zirconium compounds of sulfonic acids are disclosed which have the following general formula: ÄR(SO3)xÜyÄR'(SO3)x'Üy' Zr Ä(O3S)x''R''Üy''Ä(O3S)x'''R'''Üy''' where R, R', R'', R''' are independently substituted or unsubstituted, alkyl, alkylene, aryl or alkaryl radicals and x, x', x'', x''', y, y', y'' and y''' are sufficient in value to supply 4 sulfonate groups to the molecule, and the use of such zirconium compounds as catalysts in organic chemical reactions.
Patent EP-0737703-B1 (EP)
Inventor: SHALABY SHALABY W
IPC: A61K47/34
Filed: 1996-04-12
Granted: 2003-06-25
Abstract: The present invention provides novel hydrogel-forming, self-solvatirig, absorbable polyester copolymers capable of selective, segmental association into compliant hydrogels upon contacting aqueous environment. Pharmaceutical formulations comprising the novel polyester copolymers of the invention are also disclosed which provide a protective barrier to prevent post-surgical adhesion, can be used to treat of defects in conduits such as blood vessels, and for controlled release of a biologically active agent for modulating cellular events such as wound healing and tissue regeneration or therapeutic treatment of diseases such as infection of the periodontium, dry socket, bone, skin, vaginal, and nail infections.
Patent EP-0767097-B1 (EP)
Inventor: JENKER ERWIN
IPC: B62B3/10
Filed: 1996-08-03
Granted: 1999-11-03
Abstract: The rectangular mobile frame has an upright rear frame part (14) and side frame parts designed to swivel inwards about a vertical swivel axis. The front and top frame arms (36,38) of the two side parts are arranged detachable from their rear and lower frame arms. The lower frame arms can have a box profiled section. The two removable frame arms fit together to form a rod (74) and each rod can be set up inclined towards the rear frame part on one of the lower frame arms.
Patent EP-0764783-B1 (EP)
Inventor: JAEGER SEBASTIAN
IPC: F04C2/107
Filed: 1996-08-20
Granted: 2001-02-28
Abstract: The pump rotor (3) is made of rigid material and is driven by an electric motor. To reduce the motor starting current, the lining (5) is prestressed at 5 to 15% against the rotor. The lining surface (8) bearing against the rotor contains a fine structure between protrusions (15), so as to accommodate liquid or pasty ingredients in the medium handled. The protrusions can be formed by rounded bosses, and the structure can resemble flakes nesting together. The protrusions can be in rows one behind the other, those in adjacent rows being offset for half the intervals between them.
Patent EP-0764414-B1 (EP)
Inventor: KUSCH DIETER
IPC: A47C1/024
Filed: 1996-09-13
Granted: 2001-04-04
Abstract: The bottom of the seat back is secured at each end by two pairs of screw fasteners, set one pair above the other pair. Each pair has a securing screw (7,10) threaded through the seat back and into the seat support frame (4). The other screw has its head between the seat back and the support frame and acts as the adjusting screw. The adjusting screw is accessed via narrow tooling holes through the bottom of the seat. Metal support plates are positioned between the screw fasteners and the seat back, and provide the flexibility of the seat.
Patent EP-0807027-B1 (EP)
Inventor: ROTHMAN ULF
IPC: B60C23/00
Filed: 1996-02-06
Granted: 2001-12-05
Abstract: PCT No. PCT/SE96/00137 Sec. 371 Date Nov. 28, 1997 Sec. 102(e) Date Nov. 28, 1997 PCT Filed Feb. 6, 1997 PCT Pub. No. WO96/24499 PCT Pub. Date Aug. 15, 1996A device for operating a valve (1), preferably for a tire valve of a car, where a valve actuating pin (3) is biased to a valve-closing extended position and is to be depressed for opening the valve, has a disc-shaped operating member (6) arranged in a housing (4), which is mounted on the valve. The operating member is provided with a central recess (6') with gradually sloping sides in its surface facing the pin. An operating rod (7) is axially movably arranged in the housing substantially in line with the pin, the rod engaging the recess with one of its ends and the pin with the other.
Patent EP-0830258-B1 (EP)
Title: Registration form
Inventor: GROOTVELD JAN ARIE FREDERIK
IPC: B42D15/10
Filed: 1996-06-06
Granted: 1999-03-10
Abstract: PCT No. PCT/NL96/00222 Sec. 371 Date Dec. 5, 1997 Sec. 102(e) Date Dec. 5, 1997 PCT Filed Sep. 19, 1996 PCT Pub. No. WO96/39306 PCT Pub. Date Dec. 12, 1996The invention relates to a registration form (1) for the registration of one or more particulars of a person or an object and of an identification means of that person or object, and for coupling the particulars and the identification mark to a registration means, to the registration mark. The form (1) comprises, at least for a part, an interacting upper part and under part which are detachable and reattachable to each other and between which upper part and under part the identification means can be visibly incorporated.
Patent EP-0829147-B1 (EP)
Inventor: SIH GILBERT C
IPC: H04Q3/42
Filed: 1996-05-31
Granted: 2007-09-26
Abstract: A system and method for detecting convergence in an echo canceller prevent false convergence from occurring as a result of receiving only tones in an input signal. An adaptive filter is used in an echo canceller to estimate an echo signal produced by an unknown echo channel. The estimated echo signal is subtracted from the return signal to remove the echo produced by the unknown echo channel. To prevent the echo canceller from falsely converging on a signal which contains only tones a system and method are provided for detecting the presence of tones in the absence of other frequencies. Filter taps of the adaptive filter are filtered to produce a filtered signal. The amount of energy in the filtered signal is compared to the amount of energy in the unfiltered filter taps to determine whether only tones have been present. If only tones have been present, the echo canceller is not allowed to reduce the adaptation step size of the adaptive filter.
Patent EP-0957958-B1 (EP)
Inventor: VUILLE DANIEL
IPC: A61M5/32
Filed: 1996-07-02
Granted: 2003-10-01
Abstract: PCT No. PCT/CH96/00243 Sec. 371 Date Dec. 12, 1997 Sec. 102(e) Date Dec. 12, 1997 PCT Filed Jul. 2, 1996 PCT Pub. No. WO97/02060 PCT Pub. Date Jan. 23, 1997An automatic needle retraction device includes a housing and retraction device for completely retracting a needle back into the housing after use. A selector switch device includes an equalization part, which produces a negative pressure to accept the fluid compressed during the retraction of the hollow needle. Thus, during retraction of the needle, compressed injection solution is not sprayed outward from the needle.
Patent EP-0914325-B1 (EP)
Inventor: WALLACH DAVID
IPC: C12N15/63
Filed: 1996-06-14
Granted: 2009-05-13
Abstract: The present invention provides proteins capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 protein, which in turn binds to the intracellular domain of the FAS receptor or to another protein TRADD which binds to the p55 receptor. In addition, peptide inhibitors which interfere with the proteolytic activity of MORT-1-binding proteins having proteolytic activity are provided as well as a method of designing them.
Patent EP-0786173-B1 (EP)
Inventor: KINNUNEN KIMMO
IPC: H04B7/26
Filed: 1996-08-13
Granted: 2000-04-19
Abstract: PCT No. PCT/FI96/00436 Sec. 371 Date Apr. 14, 1997 Sec. 102(e) Date Apr. 14, 1997 PCT Filed Aug. 13, 1996 PCT Pub. No. WO97/07603 PCT Pub. Date Feb. 27, 1997A method of synchronizing a telecommunications connection in a mobile communications system having at least one base station, and having a first and at least a second mobile station communicating on a direct mode channel, the first mobile station operating on the direct mode channel transmits a registration message to the base station of the mobile communications system on a system channel of the mobile communications system, the registration message indicating a wish of the first mobile station to operate in dual watch mode on the control channel of the mobile communications system. In response to the registration message, a specific control channel of the base station and the timing information related to the control channel are communicated to the first mobile station, the first mobile station switches to dual watch mode in order to communicate either on the direct mode channel or on the allocated control channel during the time indicated by the timing information.
Patent EP-0844874-B1 (EP)
Inventor: BROOKS PETER
IPC: A61K31/421
Filed: 1996-08-13
Granted: 2005-11-09
Abstract: The present invention describes methods for inhibiting angiogenesis in tissues using vitronectin  alpha v beta 5 antagonists. The  alpha v beta 5-mediated angiogenesis is correlated with exposure to cytokines including vascular endothelial growth factor, transforming growth factor- alpha  and epidermal growth factor. Inhibition of  alpha v beta 5-mediated angiogenesis is particularly preferred in vascular endothelial ocular neovascular diseases, in tumor growth and in inflammatory conditions, using therapeutic compositions containing  alpha v beta 5 antagonists.
Patent EP-0852521-B1 (EP)
Inventor: GAYDOUL JUERGEN
IPC: B21B45/08
Filed: 1996-09-20
Granted: 1999-06-23
Abstract: PCT No. PCT/EP96/04126 Sec. 371 Date May 20, 1998 Sec. 102(e) Date May 20, 1998 PCT Filed Sep. 20, 1996 PCT Pub. No. WO97/11797 PCT Pub. Date Apr. 3, 1997An apparatus for descaling semi-finished products, such as thin slabs or steel strips in rolling mills by highly pressurized water that is sprayed through a nozzle device onto the surface of the semi-finished product is characterized in that the nozzle device is movable with a vertical component above the surface of the semi-finished product by means of a drive. The drive can be controlled by a control device that receives a target distance as input value and an actual distance between the nozzle device and the surface of the semi-finished product detected by means of a distance sensor. The control device supplies an output signal via a signal line to the drive for resetting any deviation to zero. Hence, the nozzle device is always kept at a desired target distance even if humps such as bulgings occur on the surface of the semi-finished product.